SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense volatility as investors brace for critical earnings results, with community discourse divided between fears of a sector-wide sell-off and bullish expectations for record-breaking growth. Market participants are intensely focused on the upcoming forward guidance, as the stock has experienced significant pre-earnings price swings that have triggered stop-losses and sparked widespread debate over potential market manipulation.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's has become a central focus for retail traders attempting to trigger a short squeeze, driven by high trading volume and a viral movement to support the fast-food chain. While supporters are highlighting the stock's dividend yield and long-term turnaround potential, skeptics argue that the surge is a hype-driven event detached from the company's significant debt load and core fundamentals.

Roundhill ETF Trust - Roundhill Memory ETF

The $DRAM ETF is trending as investors aggressively position themselves ahead of upcoming Micron Technology earnings, betting that ongoing structural memory supply shortages will drive further upside. The community remains highly active in debating whether this represents a sustainable re-rating of the memory sector or an overextended bubble, with many traders holding firm despite recent volatility.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is seeing significant investor attention centered on its upcoming Investor Day, where the company is expected to showcase its strategic pivot toward data center expansion, custom AI silicon, and edge computing. While the stock has experienced volatility alongside the broader semiconductor sector, the community is actively debating the strength of its hyperscaler partnerships and long-term potential as a diversified AI infrastructure player rather than just a mobile chip supplier.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense investor frustration as the stock struggles through a persistent downtrend, with many community members expressing concern over heavy capital expenditures on AI data centers and a perceived lack of leadership transparency. While some investors view the recent price drop as a value opportunity for long-term accumulation, others remain deeply skeptical, debating whether the stock will continue to lag behind broader market recoveries or eventually rebound as infrastructure investments pay off.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility driven by a broader semiconductor selloff and profit-taking ahead of critical memory sector earnings. While some investors are viewing the decline as a technical shakeout, others are engaged in heated debate over whether the AI-fueled memory cycle is peaking or merely pausing.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is facing significant downward pressure and intense community scrutiny following a lawsuit against the U.S. Department of Defense regarding its inclusion on a military-linked blacklist. Investors are deeply divided, with many expressing frustration over persistent share price declines while others argue the stock is an oversold deep-value opportunity and are actively accumulating shares in anticipation of a structural reversal.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is currently experiencing a significant surge in trading volume and price action, with market participants actively discussing potential M&A activity and the impact of large institutional buying. The community is focused on critical resistance levels near the double-digit mark, while speculating on whether this momentum signals a long-awaited breakout or another temporary spike in a historically volatile ticker.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is experiencing significant volatility as investors weigh the impact of a hawkish Federal Reserve outlook against sustained industrial demand and long-term supply deficits. Community discussions are split between those viewing the current pullback as a generational buying opportunity and frustrated participants who are questioning the strength of the thesis amidst a strengthening dollar and persistent price weakness.

Direxion Shares ETF Trust - Direxion Daily MU Bull 2X ETF

Direxion Daily MU Bull 2X Shares

Investors are aggressively buying into $MUU as they lean into the memory chip sector's growth, with the community viewing recent volatility as an engineered shakeout rather than a fundamental flaw. Discussions are dominated by high-conviction bullish sentiment ahead of earnings, as traders weigh the 2x leverage volatility against the massive long-term potential of the memory super-cycle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Neurocrine (NBIX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Neurocrine (NBIX) could produce exceptional returns because of its solid growth attributes.

Best Momentum Stocks to Buy for June 24th

NBIX, ILPT and CASY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 24th, 2026.

New Strong Buy Stocks for June 24th

BY, NVGS, NBIX, TFII and BG have been added to the Zacks Rank #1 (Strong Buy) List on June 24th, 2026.

Best Value Stocks to Buy for June 24th

NVGS, BY and NBIX made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 24th, 2026.

Soleno Therapeutics Presents New VYKAT XR (diazoxide choline) Data at ENDO 2026 Demonstrating Meaningful and Durable Improvements in Hyperphagia and Behavioral Symptoms in Prader-Willi Syndrome Following Randomized Withdrawal Period

Soleno Therapeutics Presents New VYKAT XR (diazoxide choline) Data at ENDO 2026 Demonstrating Meaningful and Durable Improvements in Hyperphagia and Behavioral Symptoms in Prader-Willi Syndrome Following Randomized Withdrawal Period Soleno Therapeutics Presents New VYKAT XR (diazoxide choline) Data...

Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11Hydroxylase Deficiency at ENDO 2026

Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11Hydroxylase Deficiency at ENDO 2026 Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY (crinecerfont) in Patients...

Neurocrine Biosciences Presents New Two-Year CRENESSITY (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026

Neurocrine Biosciences Presents New Two-Year CRENESSITY (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026 Neurocrine Biosciences Presents New Two-Year CRENESSITY (crinecerfont) Data Demonstrating Improved Growth...

Neurocrine Biosciences Presents New Two-Year CRENESSITY (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026

Neurocrine Biosciences Presents New Two-Year CRENESSITY (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026 Neurocrine Biosciences Presents New Two-Year CRENESSITY (crinecerfont) Data Demonstrating...

Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of INGREZZA (valbenazine) Capsules Across a Broad Range of Patients

Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of INGREZZA (valbenazine) Capsules Across a Broad Range of Patients Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive...

Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities

Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities Neurocrine Biosciences Presents New Data Highlighting Functional and...

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

Neurocrine-Soleno Deal Garners Wall Street Praise — Analyst Applauds Business Development Acumen

Equity

Bullish Sentiment

$UBER only

$INTC only

Both $UBER and $INTC

Neither

Nancy Pelosi recently disclosed trades in both Uber ($UBER) and Intel ($INTC) - are you following her into either? Cast your vote below.

Are you following Nancy Pelosi into her latest trades - Uber ($UBER) and Intel ($INTC)?

Feed

News

Sentiment

Earnings

Fundamentals

Info

NBIXNeurocrine Biosciences, Inc.

Fundamentals

Latest NBIX News